The holy grails of health care are precision health and personalized medicine. While the two phrases may appear to be interchangeable, success in one leads to success in the other: achieving customized medicine will result in precision health for individuals and the public as a whole. Precision health is a type of medicine that takes into account a person's genetic, environmental, and societal elements in addition to their current health status. We anticipate a greater emphasis in the future on quantitative imaging technologies aimed at improving diagnosis and therapy choices, which we refer to as "Precision Imaging." Precision Imaging is not the same as "Precision Medicine," but it is supplementary to it. Precision medicine focuses on taking into consideration customised genetic, environmental, and lifestyle profiles (and their variability) in healthcare, whereas traditional diagnosis and categorization relied solely on individual phenotypes acquired from various medical examinations, including imaging.
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Personalized and precision medicine (PPM) can be established as a unique healthcare model through biodesign-driven and inspired biotech, translational applications. This approach aims to ensure human healthcare, wellness, and biosafety.
Sergey Suchkov, Institute for Biotech & Global Health of RosBioTech and A.I. Evdokimov MGMSU, Russian Federation
Title : Monitoring folds localization in ultra-thin transition metal dichalcogenides using optical harmonic generation
Ahmed Raza Khan, Australian National University, Australia
Title : A systematic review of regulatory approaches for Direct- To- Consumers (DTC) genetic testing
Kavitha Palaniappan, Duke-NUS Medical School, Singapore
Title : Regulatory framework of in vitro diagnostic and artificial intelligence for precision medicine
Pei Ting Sarah Chou, Regulatory Affairs Professionals Society, Taiwan
Title : Unraveling cancer stem cell signatures in circulating tumor cells of metastatic colorectal cancer: Investigating ALDH1A1 and the repurposing potential of disulfiram via scRNA-seq
Nurul Syakima Ab Mutalib, Universiti Kebangsaan Malaysia, Malaysia